カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の抗ウイルス剤市場2022年：逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系調節剤

◆英語タイトル：Global Antiviral Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8739 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：95 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

抗ウイルス剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の抗ウイルス剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

抗ウイルス剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系調節剤

用途別セグメントは次のように区分されます。
・肝炎治療薬、HIV/AIDS治療薬、ヘルペス治療薬、インフルエンザ治療薬

世界の抗ウイルス剤市場の主要な市場プレーヤーは以下のとおりです。
・Roche、Johnson & Johnson、Merck、Novartis、Bristol-Myers Squibb、Gilead Sciences、GlaxoSmithKline、AbbVie

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、抗ウイルス剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な抗ウイルス剤メーカーの企業概要、2019年～2022年までの抗ウイルス剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な抗ウイルス剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別抗ウイルス剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの抗ウイルス剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での抗ウイルス剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および抗ウイルス剤の産業チェーンを掲載しています。
・第13、14、15章では、抗ウイルス剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Roche、Johnson & Johnson、Merck、Novartis、Bristol-Myers Squibb、Gilead Sciences、GlaxoSmithKline、AbbVie
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系調節剤
・用途別分析2017年-2028年：肝炎治療薬、HIV/AIDS治療薬、ヘルペス治療薬、インフルエンザ治療薬
・抗ウイルス剤の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・抗ウイルス剤のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・抗ウイルス剤のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・抗ウイルス剤の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・抗ウイルス剤の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Antiviral Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antiviral Drugs market size is estimated to be worth US$ 42060 million in 2021 and is forecast to a readjusted size of USD 52240 million by 2028 with a CAGR of 3.1% during review period. Hepatitis Therapeutics accounting for % of the Antiviral Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Reverse Transcriptase Inhibitors segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antiviral Drugs include Roche, Johnson & Johnson, Merck, Novartis, and Bristol-Myers Squibb, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antiviral Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
Market segment by Application can be divided into
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
The key market players for global Antiviral Drugs market are listed below:
Roche
Johnson & Johnson
Merck
Novartis
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
AbbVie
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antiviral Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antiviral Drugs, with price, sales, revenue and global market share of Antiviral Drugs from 2019 to 2022.
Chapter 3, the Antiviral Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antiviral Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antiviral Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antiviral Drugs.
Chapter 13, 14, and 15, to describe Antiviral Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Antiviral Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antiviral Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Reverse Transcriptase Inhibitors
1.2.3 Protease Inhibitors
1.2.4 Fusion Inhibitors
1.2.5 Immune System Modulators
1.3 Market Analysis by Application
1.3.1 Overview: Global Antiviral Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hepatitis Therapeutics
1.3.3 HIV/AIDS Therapeutics
1.3.4 Herpes Therapeutics
1.3.5 Influenza Therapeutics
1.4 Global Antiviral Drugs Market Size & Forecast
1.4.1 Global Antiviral Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antiviral Drugs Sales in Volume (2017-2028)
1.4.3 Global Antiviral Drugs Price (2017-2028)
1.5 Global Antiviral Drugs Production Capacity Analysis
1.5.1 Global Antiviral Drugs Total Production Capacity (2017-2028)
1.5.2 Global Antiviral Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antiviral Drugs Market Drivers
1.6.2 Antiviral Drugs Market Restraints
1.6.3 Antiviral Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Antiviral Drugs Product and Services
2.1.4 Roche Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Antiviral Drugs Product and Services
2.2.4 Johnson & Johnson Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Antiviral Drugs Product and Services
2.3.4 Merck Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Antiviral Drugs Product and Services
2.4.4 Novartis Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb Antiviral Drugs Product and Services
2.5.4 Bristol-Myers Squibb Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Gilead Sciences
2.6.1 Gilead Sciences Details
2.6.2 Gilead Sciences Major Business
2.6.3 Gilead Sciences Antiviral Drugs Product and Services
2.6.4 Gilead Sciences Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Antiviral Drugs Product and Services
2.7.4 GlaxoSmithKline Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Antiviral Drugs Product and Services
2.8.4 AbbVie Antiviral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antiviral Drugs Breakdown Data by Manufacturer
3.1 Global Antiviral Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antiviral Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antiviral Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Antiviral Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Antiviral Drugs Manufacturer Market Share in 2021
3.5 Global Antiviral Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antiviral Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antiviral Drugs Market Size by Region
4.1.1 Global Antiviral Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Antiviral Drugs Revenue by Region (2017-2028)
4.2 North America Antiviral Drugs Revenue (2017-2028)
4.3 Europe Antiviral Drugs Revenue (2017-2028)
4.4 Asia-Pacific Antiviral Drugs Revenue (2017-2028)
4.5 South America Antiviral Drugs Revenue (2017-2028)
4.6 Middle East and Africa Antiviral Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antiviral Drugs Sales in Volume by Type (2017-2028)
5.2 Global Antiviral Drugs Revenue by Type (2017-2028)
5.3 Global Antiviral Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antiviral Drugs Sales in Volume by Application (2017-2028)
6.2 Global Antiviral Drugs Revenue by Application (2017-2028)
6.3 Global Antiviral Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antiviral Drugs Sales by Type (2017-2028)
7.2 North America Antiviral Drugs Sales by Application (2017-2028)
7.3 North America Antiviral Drugs Market Size by Country
7.3.1 North America Antiviral Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Antiviral Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antiviral Drugs Sales by Type (2017-2028)
8.2 Europe Antiviral Drugs Sales by Application (2017-2028)
8.3 Europe Antiviral Drugs Market Size by Country
8.3.1 Europe Antiviral Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Antiviral Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antiviral Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Antiviral Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Antiviral Drugs Market Size by Region
9.3.1 Asia-Pacific Antiviral Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antiviral Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antiviral Drugs Sales by Type (2017-2028)
10.2 South America Antiviral Drugs Sales by Application (2017-2028)
10.3 South America Antiviral Drugs Market Size by Country
10.3.1 South America Antiviral Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Antiviral Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antiviral Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Antiviral Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Antiviral Drugs Market Size by Country
11.3.1 Middle East & Africa Antiviral Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antiviral Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antiviral Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antiviral Drugs
12.3 Antiviral Drugs Production Process
12.4 Antiviral Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antiviral Drugs Typical Distributors
13.3 Antiviral Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Antiviral Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Antiviral Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Antiviral Drugs Product and Services
Table 6. Roche Antiviral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Antiviral Drugs Product and Services
Table 10. Johnson & Johnson Antiviral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Antiviral Drugs Product and Services
Table 14. Merck Antiviral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Antiviral Drugs Product and Services
Table 18. Novartis Antiviral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb Major Business
Table 21. Bristol-Myers Squibb Antiviral Drugs Product and Services
Table 22. Bristol-Myers Squibb Antiviral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 24. Gilead Sciences Major Business
Table 25. Gilead Sciences Antiviral Drugs Product and Services
Table 26. Gilead Sciences Antiviral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 28. GlaxoSmithKline Major Business
Table 29. GlaxoSmithKline Antiviral Drugs Product and Services
Table 30. GlaxoSmithKline Antiviral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. AbbVie Basic Information, Manufacturing Base and Competitors
Table 32. AbbVie Major Business
Table 33. AbbVie Antiviral Drugs Product and Services
Table 34. AbbVie Antiviral Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Antiviral Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Antiviral Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Antiviral Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Antiviral Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Antiviral Drugs Production Site of Key Manufacturer
Table 40. Antiviral Drugs New Entrant and Capacity Expansion Plans
Table 41. Antiviral Drugs Mergers & Acquisitions in the Past Five Years
Table 42. Global Antiviral Drugs Sales by Region (2017-2022) & (K Units)
Table 43. Global Antiviral Drugs Sales by Region (2023-2028) & (K Units)
Table 44. Global Antiviral Drugs Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Antiviral Drugs Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Antiviral Drugs Sales by Type (2017-2022) & (K Units)
Table 47. Global Antiviral Drugs Sales by Type (2023-2028) & (K Units)
Table 48. Global Antiviral Drugs Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Antiviral Drugs Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Antiviral Drugs Price by Type (2017-2022) & (USD/Unit)
Table 51. Global Antiviral Drugs Price by Type (2023-2028) & (USD/Unit)
Table 52. Global Antiviral Drugs Sales by Application (2017-2022) & (K Units)
Table 53. Global Antiviral Drugs Sales by Application (2023-2028) & (K Units)
Table 54. Global Antiviral Drugs Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Antiviral Drugs Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Antiviral Drugs Price by Application (2017-2022) & (USD/Unit)
Table 57. Global Antiviral Drugs Price by Application (2023-2028) & (USD/Unit)
Table 58. North America Antiviral Drugs Sales by Country (2017-2022) & (K Units)
Table 59. North America Antiviral Drugs Sales by Country (2023-2028) & (K Units)
Table 60. North America Antiviral Drugs Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Antiviral Drugs Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Antiviral Drugs Sales by Type (2017-2022) & (K Units)
Table 63. North America Antiviral Drugs Sales by Type (2023-2028) & (K Units)
Table 64. North America Antiviral Drugs Sales by Application (2017-2022) & (K Units)
Table 65. North America Antiviral Drugs Sales by Application (2023-2028) & (K Units)
Table 66. Europe Antiviral Drugs Sales by Country (2017-2022) & (K Units)
Table 67. Europe Antiviral Drugs Sales by Country (2023-2028) & (K Units)
Table 68. Europe Antiviral Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Antiviral Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Antiviral Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Europe Antiviral Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Europe Antiviral Drugs Sales by Application (2017-2022) & (K Units)
Table 73. Europe Antiviral Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Antiviral Drugs Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Antiviral Drugs Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Antiviral Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Antiviral Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Antiviral Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Antiviral Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Antiviral Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Antiviral Drugs Sales by Application (2023-2028) & (K Units)
Table 82. South America Antiviral Drugs Sales by Country (2017-2022) & (K Units)
Table 83. South America Antiviral Drugs Sales by Country (2023-2028) & (K Units)
Table 84. South America Antiviral Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Antiviral Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Antiviral Drugs Sales by Type (2017-2022) & (K Units)
Table 87. South America Antiviral Drugs Sales by Type (2023-2028) & (K Units)
Table 88. South America Antiviral Drugs Sales by Application (2017-2022) & (K Units)
Table 89. South America Antiviral Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Antiviral Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Antiviral Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Antiviral Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Antiviral Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Antiviral Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Antiviral Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Antiviral Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Antiviral Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Antiviral Drugs Raw Material
Table 99. Key Manufacturers of Antiviral Drugs Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Antiviral Drugs Typical Distributors
Table 103. Antiviral Drugs Typical Customers
List of Figures
Figure 1. Antiviral Drugs Picture
Figure 2. Global Antiviral Drugs Revenue Market Share by Type in 2021
Figure 3. Reverse Transcriptase Inhibitors
Figure 4. Protease Inhibitors
Figure 5. Fusion Inhibitors
Figure 6. Immune System Modulators
Figure 7. Global Antiviral Drugs Revenue Market Share by Application in 2021
Figure 8. Hepatitis Therapeutics
Figure 9. HIV/AIDS Therapeutics
Figure 10. Herpes Therapeutics
Figure 11. Influenza Therapeutics
Figure 12. Global Antiviral Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Antiviral Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Antiviral Drugs Sales (2017-2028) & (K Units)
Figure 15. Global Antiviral Drugs Price (2017-2028) & (USD/Unit)
Figure 16. Global Antiviral Drugs Production Capacity (2017-2028) & (K Units)
Figure 17. Global Antiviral Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Antiviral Drugs Market Drivers
Figure 19. Antiviral Drugs Market Restraints
Figure 20. Antiviral Drugs Market Trends
Figure 21. Global Antiviral Drugs Sales Market Share by Manufacturer in 2021
Figure 22. Global Antiviral Drugs Revenue Market Share by Manufacturer in 2021
Figure 23. Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Antiviral Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Antiviral Drugs Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Antiviral Drugs Sales Market Share by Region (2017-2028)
Figure 27. Global Antiviral Drugs Revenue Market Share by Region (2017-2028)
Figure 28. North America Antiviral Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Europe Antiviral Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Antiviral Drugs Revenue (2017-2028) & (USD Million)
Figure 31. South America Antiviral Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Antiviral Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Global Antiviral Drugs Sales Market Share by Type (2017-2028)
Figure 34. Global Antiviral Drugs Revenue Market Share by Type (2017-2028)
Figure 35. Global Antiviral Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Antiviral Drugs Sales Market Share by Application (2017-2028)
Figure 37. Global Antiviral Drugs Revenue Market Share by Application (2017-2028)
Figure 38. Global Antiviral Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Antiviral Drugs Sales Market Share by Type (2017-2028)
Figure 40. North America Antiviral Drugs Sales Market Share by Application (2017-2028)
Figure 41. North America Antiviral Drugs Sales Market Share by Country (2017-2028)
Figure 42. North America Antiviral Drugs Revenue Market Share by Country (2017-2028)
Figure 43. United States Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Antiviral Drugs Sales Market Share by Type (2017-2028)
Figure 47. Europe Antiviral Drugs Sales Market Share by Application (2017-2028)
Figure 48. Europe Antiviral Drugs Sales Market Share by Country (2017-2028)
Figure 49. Europe Antiviral Drugs Revenue Market Share by Country (2017-2028)
Figure 50. Germany Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Antiviral Drugs Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Antiviral Drugs Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Antiviral Drugs Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Antiviral Drugs Revenue Market Share by Region (2017-2028)
Figure 59. China Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Antiviral Drugs Sales Market Share by Type (2017-2028)
Figure 66. South America Antiviral Drugs Sales Market Share by Application (2017-2028)
Figure 67. South America Antiviral Drugs Sales Market Share by Country (2017-2028)
Figure 68. South America Antiviral Drugs Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Antiviral Drugs Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Antiviral Drugs Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Antiviral Drugs Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Antiviral Drugs Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Antiviral Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Antiviral Drugs in 2021
Figure 80. Manufacturing Process Analysis of Antiviral Drugs
Figure 81. Antiviral Drugs Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の抗ウイルス剤市場2022年：逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系調節剤(Global Antiviral Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の抗ウイルス剤市場2022年：逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系調節剤

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp